Cited 0 times in

The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma

DC Field Value Language
dc.contributor.author김범경-
dc.date.accessioned2025-02-03T08:46:33Z-
dc.date.available2025-02-03T08:46:33Z-
dc.date.issued2024-01-
dc.identifier.issn1976-2283-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/201848-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherEditorial Office of Gut and Liver-
dc.relation.isPartOfGUT AND LIVER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntibodies, Monoclonal / therapeutic use-
dc.subject.MESHCarcinoma, Hepatocellular* / drug therapy-
dc.subject.MESHCarcinoma, Hepatocellular* / pathology-
dc.subject.MESHHumans-
dc.subject.MESHImmune Checkpoint Inhibitors / therapeutic use-
dc.subject.MESHImmunotherapy-
dc.subject.MESHLiver Neoplasms* / drug therapy-
dc.subject.MESHLiver Neoplasms* / pathology-
dc.subject.MESHPhenylurea Compounds / pharmacology-
dc.subject.MESHPhenylurea Compounds / therapeutic use-
dc.titleThe Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorBeom Kyung Kim-
dc.identifier.doi10.5009/gnl230505-
dc.contributor.localIdA00487-
dc.relation.journalcodeJ00954-
dc.identifier.eissn2005-1212-
dc.identifier.pmid38221815-
dc.contributor.alternativeNameKim, Beom Kyung-
dc.contributor.affiliatedAuthor김범경-
dc.citation.volume18-
dc.citation.number1-
dc.citation.startPage3-
dc.citation.endPage4-
dc.identifier.bibliographicCitationGUT AND LIVER, Vol.18(1) : 3-4, 2024-01-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.